Comerica Bank
MDGL icon

Comerica Bank’s Madrigal Pharmaceuticals MDGL Stock Holding History

Comerica Bank’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$433K Sell
743
-16
-2% -$8.17K ﹤0.01% 1926
2025
Q3 		$348K Buy
759
+2
+0.3% +$746 ﹤0.01% 2063
2025
Q2 		$229K Sell
757
-26
-3% -$7.75K ﹤0.01% 2253
2025
Q1 		$259K Buy
783
+84
+12% +$27.6K ﹤0.01% 2183
2024
Q4 		$216K Buy
699
+16
+2% +$4.5K ﹤0.01% 2279
2024
Q3 		$145K Buy
683
+62
+10% +$15.9K ﹤0.01% 2418
2024
Q2 		$174K Buy
621
+249
+67% +$59.3K ﹤0.01% 2317
2024
Q1 		$99.2K Buy
372
+320
+615% +$75.4K ﹤0.01% 2547
2023
Q4 		$12.1K Buy
52
+24
+86% +$4.2K ﹤0.01% 3111
2023
Q3 		$4.13K Buy
+28
New +$5.27K ﹤0.01% 3413

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Comerica Bank's MDGL Position: Q4 2025 in Review

Comerica Bank reduced its Madrigal Pharmaceuticals (MDGL) stake by 2.1% in Q4 2025, selling an estimated $8.17K and leaving 743 shares worth $433K. The position accounts for ﹤0.01% of the portfolio, ranked #1926.

Comerica Bank first reported a position in MDGL in Q3 2023 and has held it in 10 quarters since. 387 funds tracked by Wall St. Rank hold MDGL as of Q4 2025.

  • Comerica Bank held 743 shares of Madrigal Pharmaceuticals worth $433K as of Q4 2025.
  • Comerica Bank sold 16 Madrigal Pharmaceuticals shares in Q4 2025, an estimated $8.17K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #1926 holding.
  • Comerica Bank first reported a position in Madrigal Pharmaceuticals in Q3 2023 and has held it in 10 quarters since.
  • 387 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.